SCIENTIFIC BACKGROUND

PAH

Autosomal recessive phenylketonuria (PKU) is the most common genetic disorder of amino acid metabolism (prevalence 1:7,500-8,500). Due to a defect in phenylalanine hydroxylase (PAH), the amino acid phenylalanine can no longer be sufficiently metabolized to tyrosine. This leads to an unphysiological accumulation of phenylalanine, which, if left untreated, results in pronounced brain damage and consequent severe psychomotor retardation. The molecular cause is found in pathogenic variants in the PAH gene, which codes for phenylalanine hydroxylase. A large number of variants have been described that lead either to reduced enzyme activity or to complete failure of the enzyme. This also explains the existing genotype-phenotype correlation. The combination of two "mild variants" or a "mild" with a "severe variant" usually leads to mild hyperphenylalaninemia or mild phenylketonuria, respectively. The combination of two "severe variants" predominantly leads to classic phenylketonuria. However, this genotype-phenotype correlation is not always present, and variants have been described that can lead to different phenotypes in homozygous form.

 

Therapy of PKU is via a strict low phenylalanine diet. Another treatment option is the administration of tetrahydrobiopterin (BH4), a cofactor of phenylalanine hydroxylase. In pharmacological doses, tetrahydrobiopterin is able to stabilize the structure of misfolded phenylalanine hydroxylase (molecular chaperone) and increase its enzyme activity. A large proportion of patients benefit from BH4 therapy. There are also genotype-phenotype correlations in the efficacy of BH4 therapy, which in many cases allow the response to therapy to be estimated in advance.

 

Diagnosis of phenylketonuria is part of newborn screening. In the case of abnormal findings, the diagnosis can be confirmed by molecular genetics. With timely initiation of therapy and adherence to the necessary dietary measures, the disease is readily treatable.

 

References
Regier and Greene CL  2000 [Updated 2017 Jan 5]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019 / Blau 2016 Hum Mutat. ;37(6):508-15 / Zurflüh et al. 2008, Hum Mutat 29:167

GENES

PAH

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Exciting news in genetic research! The Human Pangenome Reference Consortium has unveiled an improved version of the human pangenome reference. This c...

Read more

Duchenne muscular dystrophy, a rare inherited muscle disorder characterized by progressive muscle weakness and degeneration that leads to difficultie...

Read more

May 12 is International Nurses Day. It is celebrated on Florence Nightingale’s birthday. She pioneered the field of modern nursing through her dedi...

Read more

Hair loss is a common problem that affects millions of men and women around the world. While genetics is believed to be the most significant factor c...

Read more

Depression is a serious mental health issue affecting over 280 million people worldwide. Recent research has revealed a potential link between gut he...

Read more

If you are unlucky enough to suffer from migraines, you will know that a migraine is not just a bad headache. The headache and accompanying symptoms ...

Read more

Autism spectrum disorder (ASD) is a neurological developmental disorder that affects brain development and function. This affects how people learn, b...

Read more

Researchers have developed a method called "Mendelian Phenotype Search Engine" (MPSE) to identify which sick infants in the neonatal intensive care u...

Read more

Did you know that wisdom teeth are actually an evolutionary leftover from our ancient ancestors that no longer serve their original purpose? These mo...

Read more

Azoospermia is a medical condition characterized by the absence of sperm in the ejaculate and is a major cause of male infertility. It affects 1 in 1...

Read more